MARKET

NDRAW

Endra Life Sciences Inc
NDRAW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.5398
0.1849
0.1184
30,240,000.00
ENDRA Life Sciences Reports TAEUS Device Matches MRI Accuracy in Liver Disease Study
Reuters · 12/04 13:01
ENDRA’S TAEUS® LIVER MATCHES MRI-PDFF PERFORMANCE AT KEY CLINICAL THRESHOLDS, POSITIONING DEVICE FOR MASLD/MASH TRIAL USE
Reuters · 12/04 13:00
ENDRA LIFE SCIENCES INC - SECOND FEASIBILITY STUDY FOR TAEUS LIVER DEVICE BEGUN IN LONDON, ONTARIO
Reuters · 12/04 13:00
ENDRA Life Sciences CTO Resigns as CFO Compensation Terms Change
Reuters · 11/28 21:23
ENDRA Life Sciences Reports Positive Feasibility Study Results for TAEUS Liver Fat Quantification Device
Reuters · 11/20 13:01
ENDRA Life Sciences Q3 cash burn declines on cost optimization
Reuters · 11/17 13:10
ENDRA Life Sciences reports third quarter cash burn down 30% to $1.2 million
Reuters · 11/17 13:06
ENDRA LIFE SCIENCES RECAPS MAJOR MILESTONES AND NEW STRATEGIC INITIATIVES, ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS
Reuters · 11/17 13:00
More

Webull offers Endra Life Sciences Inc stock information, including NASDAQ: NDRAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NDRAW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NDRAW stock methods without spending real money on the virtual paper trading platform.